Ievgenii Karamanesht

Statistics

Publications

Citations

H-Index

Active since

2011

Affiliations

Kyiv City Clinical Oncology Center(Current)

Hôpital Claude Huriez

Janssen (Belgium)

City Clinical Hospital

Centre Hospitalier Universitaire de Nantes

Ievgenii Karamanesht is an author at Kyiv City Clinical Oncology Center specializing in pharmacology, bortezomib therapy, and hematologic malignancy pharmacotherapy.

Publications per year

2011–2015

Publications

Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study

Philippe Moreau, Halyna Pylypenko, Sebastian Grosicki et al. · The Lancet Oncology · 2011 · 917 citations

Medicine, Pharmacology, Pharmacotherapy +15

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

Meletios Α. Dimopoulos, Philippe Moreau, Antonio Palumbo et al. · The Lancet Oncology · 2015 · 849 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma

Bertrand Arnulf, Halyna Pylypenko, Sebastian Grosicki et al. · Haematologica · 2012 · 127 citations · Full text

Medicine, Oncology, Pharmacology +11

Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma

Philippe Moreau, Ievgenii Karamanesht, Maryna Kyselyova et al. · Clinical Pharmacokinetics · 2012 · 85 citations

Medicine, Pharmacokinetics, Pharmacology +14

1–4 of 4